Questions
2–4 questions in professional pharmacy/nursing exams
Difficulty
Medium-Hard
Importance
High yield for B.Pharm and MBBS University exams
Overview
Cardiovascular pharmacology focuses on drugs acting on the heart and blood vessels to manage chronic conditions like hypertension, angina, and arrhythmias. Understanding these mechanisms is vital for both clinical practice and pharmacology exams, as it requires correlating hemodynamic changes with drug classifications. Mastering this topic involves categorizing agents based on their molecular targets and physiological effects on cardiac output and systemic vascular resistance.
Antihypertensive Agents
Antihypertensives are essential for blood pressure regulation by targeting the Renin-Angiotensin-Aldosterone System (RAAS) and sympathetic outflow. They are classified based on their primary site of action, ranging from central alpha-agonists to peripheral vasodilators.
- ACE Inhibitors (e.g., Lisinopril) prevent conversion of Angiotensin I to II
- ARBs (e.g., Losartan) block AT1 receptors directly
- Calcium Channel Blockers (e.g., Amlodipine) cause vasodilation
- Beta-blockers (e.g., Atenolol) reduce cardiac output
- Thiazide diuretics are first-line therapy for uncomplicated hypertension
Diuretics
Diuretics increase the excretion of sodium and water from the kidneys, effectively reducing blood volume and preload. They are grouped by their specific site of action along the renal tubule.
- Loop diuretics (e.g., Furosemide) act on the Thick Ascending Limb of Henle
- Thiazides act on the Distal Convoluted Tubule
- Potassium-sparing diuretics (e.g., Spironolactone) act on the Collecting Duct
- Carbonic anhydrase inhibitors (e.g., Acetazolamide) are used in glaucoma
- Osmotic diuretics (e.g., Mannitol) decrease intracranial pressure
Antianginal Drugs
Antianginal drugs optimize the balance between myocardial oxygen supply and demand. They achieve this primarily through peripheral vasodilation and reducing cardiac workload.
- Organic Nitrates (e.g., Nitroglycerin) increase cGMP leading to venodilation
- Beta-blockers decrease myocardial oxygen demand by reducing heart rate
- CCBs increase coronary blood flow and reduce afterload
- Ranolazine inhibits the late sodium current in cardiac cells
Antiarrhythmic Drugs
Antiarrhythmics utilize the Vaughan Williams classification system based on the drug's effect on cardiac action potential ion channels. These drugs are critical for managing supraventricular and ventricular tachycardias.
- Class I (Sodium Channel Blockers): Quinidine, Lidocaine, Flecainide
- Class II (Beta-blockers): Propranolol, Esmolol
- Class III (Potassium Channel Blockers): Amiodarone, Sotalol
- Class IV (Calcium Channel Blockers): Verapamil, Diltiazem
- Amiodarone is unique as it exhibits properties of all four classes
Exam Tip
Always draw the relevant physiological feedback loop (like RAAS) or the cardiac action potential graph to illustrate the mechanism of action for bonus marks.
Common Mistakes
- Confusing the mechanism of ACE inhibitors with ARBs regarding bradykinin accumulation
- Failing to categorize drugs correctly according to the Vaughan Williams classification
- Neglecting the contraindications of Beta-blockers in asthmatic patients
More Revision Notes
Ready to test yourself?
Play topic-wise Cardiovascular Pharmacology questions in Aspirant Arcade — gamified MCQ practice.
Download Free